Search results
Showing 1 to 2 of 2 results for brolucizumab diabetic macular oedema
Evidence-based recommendations on brolucizumab (Beovu) for diabetic macular oedema in adults.
This guideline covers managing and monitoring diabetic retinopathy in people under the care of hospital eye services. This includes non-proliferative and proliferative diabetic retinopathy, and diabetic macular oedema.